Torsade de pointes due to methadone use in a patient with HIV and hepatitis C coinfection

Cardiology Research and Practice

Volumn 1, Issue 1, 2010, Pages

  John, Jinu ^a   Amley, Xixi ^a   Bombino, Gabriel ^a   Gitelis, Chaim ^a   Topi, Bernard ^a   Hollander, Gerald ^a   Ghosh, Joydeep ^a  

^a MAIMONIDES MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ATAZANAVIR; COTRIMOXAZOLE; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; LAMIVUDINE PLUS ZIDOVUDINE; MAGNESIUM; METHADONE; RALTEGRAVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CASE REPORT; COCAINE DEPENDENCE; DEFIBRILLATOR; DIAPHORESIS; DIZZINESS; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ECCHYMOSIS; ELECTROCARDIOGRAM; HEART VENTRICLE BIGEMINY; HEPATITIS C; HEROIN DEPENDENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTENSIVE CARE UNIT; LIVER CELL CARCINOMA; MALE; MIXED INFECTION; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; QT INTERVAL; SINUS BRADYCARDIA; SYNCOPE; TORSADE DES POINTES; UNCONSCIOUSNESS; WEAKNESS;

EID: 79959461121     PISSN: None     EISSN: 20900597     Source Type: Journal    
DOI: 10.4061/2010/524764     Document Type: Article

References (16)

1. Kirchhof P., Franz M. R., Bardai A., Wilde A. M., Giant T-U waves precede torsades de pointes in long QT syndrome: a systematic electrocardiographic analysis in patients with acquired and congenital QT prolongation Journal of the American College of Cardiology 2009 54 2 143 149
2. Kocheril A. G., Bokhari S. A. J., Batsford W. P., Sinusas A. J., Long QT(c) and torsades de pointes in human immunodeficiency virus disease Pacing and Clinical Electrophysiology 1997 20 11 2810 2816
3. Roden D. M., Taking the idio out of idiosyncratic: predicting torsades de pointes Pacing and Clinical Electrophysiology 1998 21 5 1029 1034
4. Arizona Center for Education and Research on Therapeutics. University of Arizona College of Pharmacy. Resources for Professionals, Torsades List: Drugs With a Risk of Torsades de Pointes. http://www.azcert.org/medical-pros/drug- lists/bycategory.cfm
5. Goldenberg I., Moss A. J., Zareba W., QT interval: how to measure it and what is normal Journal of Cardiovascular Electrophysiology 2006 17 3 333 336 (Pubitemid 43344951)
6. Schouten E. G., Dekker J. M., Meppelink P., Kok F. J., Vandenbroucke J. P., Pool J., QT interval prolongation predicts cardiovascular mortality in an apparently healthy population Circulation 1991 84 4 1516 1523
7. Sani M. U., Okeahialam B. N., QTc interval prolongation in patients with HIV and AIDS Journal of the National Medical Association 2005 97 12 1657 1661 (Pubitemid 41753112)
8. Villa A., Foresti V., Confalonieri F., Autonomic neuropathy and prolongation of QT interval in human immunodeficiency virus infection Clinical Autonomic Research 1995 5 1 48 52
9. Charbit B., Rosier A., Bollens D., Boccara F., Boelle P. Y., Koubaa A., Girard P. M., Funck-Brentano C., Relationship between HIV protease inhibitors and QTc interval duration in HIV-infected patients: a cross-sectional study British Journal of Clinical Pharmacology 2009 67 1 76 82
10. Anson B. D., Weaver J. G. R., Ackerman M. J., Akinsete O., Henry K., January C. T., Badley A. D., Blockade of HERG channels by HIV protease inhibitors Lancet 2005 365 9460 682 686 (Pubitemid 40260891)
11. Martell B. A., Arnsten J. H., Krantz M. J., Gourevitch M. N., Impact of methadone treatment on cardiac repolarization and conduction in opioid users American Journal of Cardiology 2005 95 7 915 918 (Pubitemid 40386816)
12. Abramson D. W., Quinn D. K., Stern T. A., Methadone-associated QTc prolongation: a case report and review of the literature Primary Care Companion to the Journal of Clinical Psychiatry 2008 10 6 470 476
13. Ehret G. B., Voide C., Gex-Fabry M., Chabert J., Shah D., Broers B., Piguet V., Musset T., Gaspoz J. M., Perrier A., Dayer P., Desmeules J. A., Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factors Archives of Internal Medicine 2006 166 12 1280 1287 (Pubitemid 43967579)
14. Athanasos P., Farquharson A. L., Compton P., Psaltis P., Hay J., Electrocardiogram characteristics of methadone and buprenorphine maintained subjects Journal of Addictive Diseases 2008 27 3 31 35
15. Nordin C., Kohli A., Beca S., Zaharia V., Grant T., Leider J., Marantz P., Importance of hepatitis C coinfection in the development of QT prolongation in HIV-infected patients Journal of Electrocardiology 2006 39 2 199 205
16. Krantz M. J., Martin J., Stimmel B., Mehta D., Haigney M. C. P., QTc interval screening in methadone treatment Annals of Internal Medicine 2009 150 6 387 395